Q2 2016 13F Holders as of 30 Jun 2016
-
Type / Class
-
Equity / Common Stock
-
Shares outstanding
-
49,633,071
-
Total 13F shares
-
31,637,934
-
Share change
-
+1,489,686
-
Total reported value
-
$942,563,404
-
Put/Call ratio
-
256%
-
Price per share
-
$29.79
-
Number of holders
-
105
-
Value change
-
+$45,435,440
-
Number of buys
-
60
-
Number of sells
-
51
Institutional Holders of PUMA BIOTECHNOLOGY, INC. - Common Stock (PBYI) as of Q2 2016
As of 30 Jun 2016 PUMA BIOTECHNOLOGY, INC. - Common Stock (PBYI) had 105 institutional shareholders that have filed 13F forms with the Securities Exchange Commission (SEC).
These institutions held a total of 31,637,934 shares of stock of the company.
Largest 10 holders included ADAGE CAPITAL PARTNERS GP, L.L.C., FMR LLC, ORBIMED ADVISORS LLC, JANUS CAPITAL MANAGEMENT LLC, VANGUARD GROUP INC, Partner Fund Management, L.P., Point72 Asset Management, L.P., STATE STREET CORP, PRICE T ROWE ASSOCIATES INC /MD/, and Capital Research Global Investors.
This table shows 105 institutional shareholders of the security as of 30 Jun 2016.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price $ |
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.